On 5 Jan 2015

We were all very sad to learn recently of the death of our friend Yehiel "Chilik" Ziv, who sadly lost his battle with cancer. We have sent our deepest condolences to his family. Chilik was a keen supporter of the Society, an active member of the Programme Committee for some years, and he will be greatly missed.

Eiji Shinto

On 18 Dec 2014

First, I would like to express my gratitude to the European Society of Coloproctology (ESCP) for the privilege of granting me a two-week travelling fellowship. My fellowship experiences at Karolinska University Hospital, St. Mark’s Hospital, and Amsterdam Medical Center were both exciting and enlightening. This invaluable experience will have a major impact on my future clinical practice and research content. Indeed, my short stay in Europe will be a memory I will cherish for the rest of my life.

Attendees seated at a workshop

On 19 Nov 2014

ESCP is delighted to announce its first regional educational masterclass Moscow, Russia, 16 April 2015, organised in conjunction with S-ECCO. This masterclass will take place on the first day of the International Congress of the Russian Association of Coloproctology meeting (16-18 April 2015) and is organised with the kind agreement and support of Professor Yury Shelygin, President of ESCP, and local organiser.

On 20 Oct 2014

This year UEG has a new interactive platform to enhance your congress experience. To follow 100 sessions via livestream and post questions directly to the podium from anywhere in the world, go to live.ueg.eu/week.
Andre D’Hoore

On 23 Sep 2014

Professor Andre D’Hoore, who chaired both the Guidelines Synthesis report session and the keynote lecture by Evaghelos Xynos, talked with us about rectal prolapse before our annual meeting in Barcelona… “There is a lot of debate on how to manage perianal Crohn’s disease. A recent publication in Gut on a ‘global consensus’ on classification, diagnosis and multidisciplinary treatment demonstrates the shortage of high quality randomised clinical trials for surgical options for patients with Crohn’s disease,” began Professor D’Hoore.